Skip Navigation LinksHome > July 2014 - Volume 25 - Issue 3 > Epidemiology of carbapenem-resistant and noncarbapenem-resis...
Text sizing:
Reviews in Medical Microbiology:
doi: 10.1097/MRM.0000000000000004

Epidemiology of carbapenem-resistant and noncarbapenem-resistant enterobacteriaceae and issues related to susceptibility testing, treatment options, and clinical outcome

Gowda, Lakshmana K.; Marie, Mohammed Ali M.

Collapse Box


Carbapenems are broad-spectrum β-lactam antibiotics that act by inhibition of cell wall synthesis. Various families of carbapenemases comprising numerous members have been identified, which may be plasmid or chromosomally encoded. More than one mechanism of carbapenem resistance (carbapenem-resistant enterobacteriaceae, CRE) has been identified with sporadic reports of CRE infection across the world. Appearance of carbapenem resistance in enterobacteriaceae is worrying as infection with these organisms has high mortality rates with fewer treatment options, which are expensive and have more adverse effects. Colistin and tigecycline are the currently available options for treatment of CRE infections. Carbapenem resistance in the enterobacteriaceae and other Gram-negative bacteria may be due to carbapenemase-mediated or noncarbapenemase-mediated mechanisms. In our review, we have compared different forms of carbapenem resistance and discussed issues related to susceptibility testing, treatment options, and subsequent clinical outcome.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.